No press releases found.
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Benzinga (Wed, 4-Feb 4:33 AM ET)
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
Liminatus Pharma - Class A trades on the NASDAQ stock market under the symbol LIMN.
As of February 4, 2026, LIMN stock price climbed to $1.11 with 11,057,979 million shares trading.
LIMN has a beta of 4.38, meaning it tends to be more sensitive to market movements. LIMN has a correlation of 0.05 to the broad based SPY ETF.
LIMN has a market cap of $30.04 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that LIMN belongs to (by Net Assets): VXF.
LIMN support price is $.94 and resistance is $1.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIMN shares will trade within this expected range on the day.
